D-0359-2022 Class II Terminated
FDA drug recall D-0359-2022 was initiated by Ascend Laboratories, LLC on Dec 21, 2021 and is designated Class II. Reason for recall: Failed impurities/degradation specifications The recall status is terminated (terminated Apr 13, 2023). Affected quantity: 42,698 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 12, 2022
- Initiation Date
- Dec 21, 2021
- Termination Date
- Apr 13, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42,698 bottles
Product description
Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, NDC 67877-584-50
Reason for recall
Failed impurities/degradation specifications
Distribution pattern
USA nationwide.
Code information
Lot #: 20140293, Exp Dec 2021; 20141525, 20141526, 20141527, Exp Mar 2022; 20143019, 20143020, 20143021, 20143022, Exp July 2022; 20144759, 20144760, 20144761, Exp Nov 22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0359-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026